Two widely used drugs for kidney patients could be banned
Wednesday, December 9, 2009
Pro Publica: A federal advisory panel appears poised to recommend that the U.S. Food and Drug Administration ban for patients with severe kidney disease the use of Omniscan , owned by General Electric Co., and Optimark, made by the Mallinckrodt unit of Covidien. Here is an earlier report on the topic.
Category: In The News;